FDA allows marketing of four “next generation” gene sequencing devices
November 19, 2013
Today the U.S. Food and Drug Administration allowed marketing of four diagnostic devices that can be used for high throughput gene sequencing, often referred to as “next generation sequencing” (NGS). These instruments, reagents, and test systems allow labs to sequence a patient’s DNA (deoxyribonucleic acid). The new technology also gives physicians the ability to take [...]
Biogas Consortium Using Genedata Selector for Metagenomics-based Process Optimization
November 19, 2013
Munich, Germany -- Genedata, a leading provider of advanced software solutions for industrial biotechnology, drug discovery, and life science research, today announced its collaboration with GOBI ("General Optimization of BIogasprocesses"), an interdisciplinary biogas research consortium consisting of leading academic and commercial members to improve the overall efficiency of biogas production. GOBI will be using Genedata [...]
November 19, 2013
SUNNYVALE, Calif. -- Arrayit Corporation (ARYC) announced today that the company has signed a Professional Services Master Agreement (PSMA) with Diagnostic Oncology Research Organization (DOCRO, Inc.). Arrayit and DOCRO will use the PSMA as a blueprint for the submission and approval of the company's OvaDx® Pre-Symptomatic Ovarian Cancer Monitoring and Screening Test, as well as [...]
LabCentral Launches Laboratory Operations; Signs American Laboratory Trading as a Gold Sponsor
November 19, 2013
CAMBRIDGE, Mass. -- LabCentral, an innovative, shared laboratory space designed as a launchpad for life-sciences startups, officially began laboratory operations on November 15th. Key to its on-schedule opening was the generous support that the nonprofit organization received from its sponsors in the form of financial contributions, equipment donations, and in-kind services. In that regard, LabCentral [...]
November 19, 2013
Salisbury, UK -- NanoSight reports on how Nanoparticle Tracking Analysis, NTA, is being used to study extracellular vesicles in the research laboratories of Dr Gregory Gores of the Mayo Clinic in Rochester, Minnesota. The Gores Laboratory of the Mayo Clinic does basic research into liver disease. One of the main research areas of interest is [...]
GE Healthcare and Cellectis agree to sublicense for stem cell patents
November 19, 2013
CHALFONT ST. GILES, UK –– GE Healthcare Life Sciences, (NYSE: GE) and Cellectis Group (Alternext: ALCLS), the global genome engineering specialist, announced today that GE Healthcare has licenced Cellectis to develop, manufacture and sell models derived from stem cells for use in drug discovery and toxicity screening. The agreement follows the announcement that GE Healthcare [...]
November 19, 2013
LITTLE ROCK, AK - Vivione Biosciences Corporation (TSXV:VBI) today announced a new three-year Cooperative Research and Development Agreement (CRADA) with the Food and Drug Administration's (FDA) National Center for Toxicological Research (NCTR). The focus of the CRADA is to expand the capability of Vivione's RAPID-B™ diagnostic system. The Vivione RAPID-B™ system is a revolutionary high-performance [...]
ALPCO Releases STELLUX™ Chemiluminescence Human Total Proinsulin ELISA
November 19, 2013
Salem, NH -- ALPCO has announced the release of its Human Total Proinsulin Chemiluminescent ELISA, the newest assay to be launched in the company’s STELLUX™ product line. Similar to other STELLUX™ products available from ALPCO, the Human Total Proinsulin ELISA boasts a broad dynamic range (5-3,000 pg/mL) and superior sensitivity (0.455 pg/mL) that is ten [...]
90 MINUTE DNA RESULTS, A FIRST OF ITS KIND, COMING TO BENSALEM
November 19, 2013
LORTON, VA –– The Bensalem Township Police Department, in conjunction with Bode Technology, is launching a new initiative in the field of DNA testing. This pilot program known as “BodeHITS – Rapid DNA” will be the first of its kind in the country for law enforcement. Bensalem Township Police Department currently has its own local [...]
Irvine Scientific Introduces New Cell Therapy Products for Cell Expansion and Differentiation
November 19, 2013
SANTA ANA, California -- Irvine Scientific, a strategic manufacturer of cell culture media, announced today the expansion of their cell therapy product portfolio with the launch of new media and recombinant growth factors. The product line is designed to provide an integrated workflow solution for the culture of human stem cells and primary cells. In [...]
